ДжиДаблЮ ФАРМА ЛИМИТЕД (GB);ОЦУКА ФАРМАСЬЮТИКАЛ КО ЛИМИТЕД (JP)
发明人:
ВЕЛАСКО ДИЕС Гильермо (ES),ГУСМАН ПАСТОР Мануэль (ES),ЛОРЕНТЕ Мар (ES),ТОРРЕС София (ES),РОДРИГЕС Фатима (ES)
申请号：
RU2010153576/15
公开号：
RU2010153576A
申请日:
2009.06.04
申请国别(地区):
RU
年份:
2012
代理人:
摘要：
1. The combination of cannabinoids tetrahydrocannabinol (THC) and cannabidiol (CBD) in a ratio of 5: 1 to 1: 5 for use in the treatment of brain tumors. ! 2. The combination of cannabinoids tetrahydrocannabinol (THC) and cannabidiol (CBD) according to claim 1, where the treatment of a brain tumor consists in reducing cell survival, suppressing cell growth or reducing tumor volume. ! 3. The combination of cannabinoids tetrahydrocannabinol (THC) and cannabidiol (CBD) according to claim 1, where the THC and CBD are in a ratio of from 2: 1 to 1: 2. ! 4. The combination of cannabinoids tetrahydrocannabinol (THC) and cannabidiol (CBD) according to claim 1, where THC and CBD are in a ratio of approximately 1: 1. ! 5. The combination of cannabinoids tetrahydrocannabinol (THC) and cannabidiol (CBD) according to claim 1, where the total content of cannabinoid is in the range from 5 to 100 mg. ! 6. The combination of cannabinoids tetrahydrocannabinol (THC) and cannabidiol (CBD) according to claim 1, where each cannabinoid is used in an amount that will be considered insufficient if used separately. ! 7. The combination of cannabinoids tetrahydrocannabinol (THC) and cannabidiol (CBD) according to claim 1, where the brain tumor is a glioma. ! 8. The combination of cannabinoids tetrahydrocannabinol (THC) and cannabidiol (CBD) according to claim 7, where the brain tumor is a polymorphic glioblastoma (PHB). ! 9. The combination of cannabinoids tetrahydrocannabinol (THC) and cannabidiol (CBD) according to claim 1, where THC and CBD are present as plant extracts, as pure components, or a combination thereof. ! 10. The combination of cannabinoids tetrahydrocannabinol (THC) and cannabidiol (CBD) according to claim 9, where the plant extract is in ph1. Комбинация каннабиноидов тетрагидроканнабинола (ТГК) и каннабидиола (КБД) в соотношении от 5:1 до 1:5 для применения в лечении опухоли головного мозга. ! 2. Комбинация каннабиноидов тетрагидроканнабинола (ТГК) и каннабидиола (КБД) по п.1
